J Ritschard
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 4
- Monoclonal and Polyclonal Antibodies Research 4
J Ritschard
11 papers receiving 793 citations
Peers
Comparison fields: 5 of 78
- Radiology, Nuclear Medicine and Imaging 769
- Oncology 278
- Immunology 139
- Pathology and Forensic Medicine 89
- Biotechnology 38
Countries citing papers authored by J Ritschard
This map shows the geographic impact of J Ritschard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Ritschard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Ritschard more than expected).
Fields of papers citing papers by J Ritschard
This network shows the impact of papers produced by J Ritschard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Ritschard. The network helps show where J Ritschard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Ritschard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 2 | |
| 2 | Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. | 1983 | 221 |
| 3 | 1981 | 274 | |
| 4 | [Use of strontium-89 in the analgesic treatment of bone metastases]. | 1980 | 4 |
| 5 | 1980 | 292 | |
| 6 | Use of limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas. | 1980 | 63 |
| 7 | [Clinical study with a sialagogue drug (sulfarlem S 25 = TTPT) in the treatment of xerostomia (author's transl)]. | 1979 | 10 |
| 8 | 1977 | 16 | |
| 9 | [Metabolism and pharmacokinetics of calcium dobesilate in humans]. | 1974 | 21 |
| 10 | 1974 | 10 | |
| 11 | [Fibrinolytic herapy of severe pulmonary hypertension. Justification, modality an criticism]. | 1970 | 2 |
| 12 | 1967 | 3 |
About J Ritschard
J Ritschard is a scholar working on Internal Medicine, Radiology, Nuclear Medicine and Imaging, Periodontics, Biotechnology and Oncology, having authored 12 papers that have together received 918 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Toxin Mechanisms and Immunotoxins (1 paper), Glycosylation and Glycoproteins Research (1 paper), Salivary Gland Disorders and Functions (1 paper), Bone health and treatments (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (769 citations), Oncology (278 citations), Immunology (139 citations), Pathology and Forensic Medicine (89 citations) and Biotechnology (38 citations). J Ritschard has collaborated with scholars based in Switzerland, Canada and France. Frequent co-authors include M. Forni, S Carrel, A Donath, C. Berche, Jean‐Pierre Mach, Pierre Alberto, F. Buchegger, J P Mach, Magali Schreyer and Christophe Girardet. Their work appears in journals such as Annals of Otology Rhinology & Laryngology, Cardiology, Spinal Cord, New England Journal of Medicine and European Journal of Drug Metabolism and Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.